HDAC9 and Miyoshi myopathy: Kikuchi et al. showed that HDACs were critical targets of BTZ and knockdown of HDAC1 enhanced BTZ-induced apoptosis, whereas HDAC1 overexpression conferred resistance to BTZ in MM cells, suggesting that combination of BTZ and HDAC inhibitors could be a more efficient treatment strategy for MM [68].